Baxter International Inc.

Industry: Medical Equipment Supplies

Fortune Rank: 185

For the 9 months ended 30 September 2005, Baxter International Inc's revenues rose 7% to $7.36B. Net income from continuing operations totaled $664M, up from $277M. Revenues reflect higher sales growth in recombinant business and bioscience business. Net income also reflects increased gross profit margins, lower special charges and higher interest income. The Company provides its expertise in medical devices, pharmaceuticals & biotechnology.

Baxter International Inc. operates as a global medical products and services company specializing in medical devices, pharmaceuticals and biotechnology to assist healthcare professionals and their patients with the treatment of medical conditions, including hemophilia, immune disorders, infectious diseases, cancer, kidney disease, trauma and other conditions. The Company operates in three segments: Medication delivery, which provides a range of intravenous (IV) solutions and specialty products that are used in combination for fluid replenishment, general anesthesia, nutrition therapy, pain management, antibiotic therapy and chemotherapy; BioScience, which develops biopharmaceuticals, bio-surgery products, vaccines and blood collection, processing and storage products and technologies for transfusion therapies, and Renal, which develops products and provides services to treat end-stage kidney disease. Baxter manufactures products in 28 countries and sells them in over 100 countries.

Baxter International Inc.

Baxter International Inc. is a Fortune 500 company. In 2010 Baxter International Inc. was ranked number 185 on the Fortune 500 list, making it the 185th largest company in the United States when judged by revenue.

Baxter International Inc. achieved revenue of $12,562.00 million in 2010 and earned a profit of $2,205.00 million.

Baxter International Inc.' rank improves

The company ranking improved in 2010, moving up the Fortune 500 list to 185th compared to 219th in 2009. This was based on its 2009 revenue of $12,348 million (a change of 0 million compared to 2010) and profits of $2,014 million (a change of $0 million compared to 2009).

Another point of view

To many investors, profits are more important than the revenue a company earns. If the Fortune 500 was ranked by profits instead of revenue then Baxter International Inc. would be ranked 63rd rather than 185th due to its profits of $2,205 in 2010.

Baxter International Inc. Revenue* Profit* Fortune Ranking

* US$ Million

USPages Latest Business News At A Glance Business Shortcuts